Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Study of Adjuvant Chemoradiotherapy of Advanced Resectable Rectal Cancer Comparing Modulation of 5-FU With Folinic Acid or With Interferon-alpha

NCT01060501 is registered in ClinicalTrials.gov with University of Ulm as lead sponsor.

NCT NCT01060501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01060501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Study of Adjuvant Chemoradiotherapy of Advanced Resectable Rectal Cancer Comparing Modulation of 5-FU With Folinic Acid or With Interferon-alpha
Lead sponsor
University of Ulm
Phase
Phase 3
Overall status
Completed
Start date
July 31, 1992
Completion date
July 31, 2009
Enrollment
796 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer